Home / Health / Women's Health Crisis: Decades of Neglect Exposed
Women's Health Crisis: Decades of Neglect Exposed
4 Dec
Summary
- Female-specific conditions receive only 5% of biopharmaceutical research spending.
- Women were excluded from clinical trials until 1993, leading to adverse drug reactions.
- Endometriosis diagnosis is delayed nearly a decade due to dismissed symptoms.
For millions of women, the quest for health answers has led to social media, a symptom of medicine's failure to address their specific needs. Female-specific conditions account for a mere 5% of biopharmaceutical research spending, with even less directed towards non-cancerous issues like menopause and infertility. This chronic underfunding creates critical gaps in pain assessment, diagnosis, and treatment.
Historically, women were excluded from clinical trials, with men's bodies considered the standard. This legacy persists, as fewer than 30% of early-stage trial participants are women, contributing to nearly double the rate of adverse drug reactions compared to men. Conditions like endometriosis often face decade-long diagnostic delays due to dismissed symptoms and low research funding.
Closing these gaps requires substantial investment in women's health research, alongside equipping patients with reliable information and training doctors for better communication. Organizations like the Gates Foundation are making significant pledges, but more is needed to ensure women receive the rigorous scientific attention their health deserves.
